Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-23-000033

Chief Scientific Officer sold 9,784 shares at an average $1.13 ($11,077)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-04 Sale : show line 1 in the form −6,381 $1.13 $7,234 367,719 D
2023-01-04 Sale : show line 2 in the form −11 $1.15 $13 367,708 D
2023-01-05 Sale : show line 3 in the form −3,372 $1.13 $3,808 364,336 D
2023-01-05 Sale : show line 4 in the form −20 $1.11 $22 364,316 D
Open-market sales · 9,784 sh · avg $1.13 · $11,077
Loading xslF345X03/wf-form4_167304333252079.xml…